Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2015: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Outline of Final Research Achievements |
This research theme pushed forward analysis for the purpose of elucidation of the action mechanism of vascularization inhibitor CXCL14/BRAK.I pushed forward analysis about combination with VEGF-A which was CXCL14/BRAK and a vascularization promotion factor, but the meaningful result was not provided.Thus, I was not able to prove that VEGF-A participated in BRAK action by this research theme.
|